Enjoy complimentary customisation on priority with our Enterprise License!
The head and neck cancer treatment market size is forecast to increase by USD 7.12 billion at a CAGR of 13.64% between 2023 and 2028. The market is experiencing significant growth due to the rising number of cancer cases and advancements in systemic drug therapies. Technological advancements in diagnosis and treatment, such as the use of Capecitabine, Cetuximab, Paclitaxel, Bleomycin, Hydroxyurea, and Docetaxel, are driving market growth. Additionally, the convenience of retail pharmacies and the increasing use of the Internet for sales channels are expanding access to these treatments. However, the high cost of treatment remains a challenge for many patients, limiting access and increasing the need for affordable options.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Market Segmentation by Therapy
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.